Cyclosporine Clinical Trials

• Cyclosporine Implant for Ocular Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00102583 - Active, not recruiting
  
  
• Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002688 - Active, not recruiting
  Leukemia, Myeloid
  
• Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00005937 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Efficacy and Safety Assessment of Cyclosporine Microemulsion C2 Monitoring Versus Tacrolimus C0 Monitoring in De Novo Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00149994 - Active, not recruiting
  Liver transplant
  
• Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00031980 - Active, not recruiting
  Anemia; Chronic Lymphocytic Leukemia; Neutropenia; Thrombocytopenia
  
• Transitioning from Cyclosporine to Alefacept in Psoriasis
  ClinicalTrials.gov Identifier: NCT00143806 - Active, not recruiting
  Psoriasis
  
• Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders
  ClinicalTrials.gov Identifier: NCT00010361 - Active, not recruiting
  Metabolism, Inborn Errors; Granulomatous Disease, Chronic
  
• Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003920 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00070291 - Recruiting
  angioimmunoblastic T-cell lymphoma
  
• Study of Muromonab-CD3 and Cyclosporine in Patients with Giant Cell Myocarditis
  ClinicalTrials.gov Identifier: NCT00027443 - Recruiting
  Myocarditis
  
• Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00009776 - Active, not recruiting
  Burkitt's Lymphoma; Lymphocytic Lymphoma
  
• Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00066794 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
  ClinicalTrials.gov Identifier: NCT00004482 - Active, not recruiting
  Myocarditis; Giant Cell Myocarditis
  
• Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004208 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients with Abnormal Glucose Metabolism from Tacrolimus to Cyclosporine Micro-Emulsion
  ClinicalTrials.gov Identifier: NCT00150085 - Active, not recruiting
  Tacrolimus-associated abnormal glucose metabolism in kidney and liver transplant recipients
  
• Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy and Cyclosporine Followed By Cryotherapy and/or Laser Therapy in Treating Patients With Newly Diagnosed Retinoblastoma in Both Eyes
  ClinicalTrials.gov Identifier: NCT00110110 - Recruiting
  intraocular retinoblastoma
  
• Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.
  ClinicalTrials.gov Identifier: NCT00170794 - Active, not recruiting
  Cardiac Transplantation
  
• Efficacy and Safety of Everolimus in a Cyclosporine Microemulsion-Free Regimen Compared to a Low-Dose Cyclosporine Microemulsion Regimen, in De Novo Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00154284 - Not yet recruiting
  Renal Transplantation
  
• The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00166816 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients
  ClinicalTrials.gov Identifier: NCT00171496 - Active, not recruiting
  Kidney Transplant
  
• Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003950 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and Mycophenolate Mofetil in High Risk-Patients With Human Immunodeficiency Virus-1
  ClinicalTrials.gov Identifier: NCT00010348 - Recruiting
  HIV Infections
  
• Fludarabine and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00119340 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
  
• Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00228020 - Active, not recruiting
  Pediatric Kidney Transplantation
  
• Extension Study of Enteric-Coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00238940 - Active, not recruiting
  Renal Transplantation
  
• Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00171509 - Active, not recruiting
  Liver Transplant
  
• Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00171743 - Active, not recruiting
  Liver Transplant
  
• Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation
  ClinicalTrials.gov Identifier: NCT00359658 - Active, not recruiting
  Heart Transplantation
  
• Interaction Between Rimonabant and Cyclosporine and Tacrolimus
  ClinicalTrials.gov Identifier: NCT00525681 - Recruiting
  Renal Transplantation
  
• Study of Enteric-Coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,
  ClinicalTrials.gov Identifier: NCT00239057 - Active, not recruiting
  Maintenance Renal Transplantation
  
• An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in “de Novo” Liver Transplantation.
  ClinicalTrials.gov Identifier: NCT00343226 - Active, not recruiting
  Liver Transplantation
  
• Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation
  ClinicalTrials.gov Identifier: NCT00359814 - Active, not recruiting
  Heart Transplantation
  
• Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002547 - Active, not recruiting
  Leukemia
  
• Peritransplant Cyclosporine in Treating Patients With Hematologic Malignancies Undergoing T-Cell Depleted Allogeneic Stem Cell Transplant Followed By T-Cell Add-Back
  ClinicalTrials.gov Identifier: NCT00079391 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Prednisone and Either Cyclosporine or Tacrolimus With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00089141 - Recruiting
  Cancer; Graft Versus Host Disease
  
• To study the effects of CD25 and low dose Cyclosporin in the treatment of active Psoriasis vulgaris
  ClinicalTrials.gov Identifier: NCT00050648 - Active, not recruiting
  Psoriasis
  
• Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00078858 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer; ...
  
• Radiation Therapy and Fludarabine Followed by Donor Peripheral Stem Cell Transplantation, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00014235 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Antibody and Delayed Cyclosporine versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00007787 - Completed
  Kidney Transplantation; Chronic Allograft Nephropathy
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003661 - Active, not recruiting
  Leukemia; Lymphoma
  
• Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00464399 - Active, not recruiting
  De Novo Renal Transplantation
  
• Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects
  ClinicalTrials.gov Identifier: NCT00481481 - Recruiting
  Transplantation
  
• Combination Therapy of Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00001964 - Active, not recruiting
  Aplastic Anemia
  
• A Study To Test An Anti-Rejection Therapy After Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00000936 - Active, not recruiting
  Kidney Transplantation
  
• Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003056 - Active, not recruiting
  Lymphoma; Leukemia
  
• Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00170885 - Recruiting
  Kidney Transplantation
  
• Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
  ClinicalTrials.gov Identifier: NCT00520260 - Recruiting
  Dry Eye Disease; Ocular Comfort
  
• A Multicentre, Open Label Ph 3b/4 Study of Subcutaneously Admin. Efalizumab (Adult Patients) With Moderate to Severe Chronic Psoriasis Failed to Respond to, or Have a Contraindication to, or Are Intolerant of Other Systemic Therapies Incl. Cyclosporine, M
  ClinicalTrials.gov Identifier: NCT00249808 - Active, not recruiting
  Candidates for Systemic Therapy for Psoriasis
  
• Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels
  ClinicalTrials.gov Identifier: NCT00154193 - Active, not recruiting
  Heart and Lung transplant
  
• Efficacy and Safety Study of Everolimus Plus Cyclosporine and Mycophenolic Acid Plus Cyclosporine in Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00251004 - Completed
  Kidney Transplantation; Graft Rejection
  
• Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00257387 - Completed
  Kidney Transplant
  
• Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00504543 - Recruiting
  Kidney Transplantation
  
• Immunotherapy Using Cyclosporine, Interferon gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070187 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Steroid Withdrawal in Pediatric Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00023244 - Active, not recruiting
  End-Stage Renal Disease
  
• Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)
  ClinicalTrials.gov Identifier: NCT00309218 - Recruiting
  Kidney Diseases
  
• Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00093587 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia
  
• Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus
  ClinicalTrials.gov Identifier: NCT00195468 - Completed
  Kidney Failure; Graft vs Host Disease
  
• Pilot Study of Allogeneic Bone Marrow Transplantation Plus Cyclosporine and Mycophenolate Mofetil to Induce Mixed Hematopoietic Chimerism in Patients With Primary T-Cell Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00008450 - Recruiting
  Purine-Pyrimidine Metabolism, Inborn Errors; Wiskott-Aldrich Syndrome; Bare Lymphocyte Syndrome; Lymphopenia; Job's Syndrome; DiGeorge Syndrome; ...
  
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00003187 - Active, not recruiting
  Lymphoma; Leukemia
  
• Peripheral Stem Cell Transplantation With Donor White Blood Cells in Treating Older Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00003196 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00005641 - Active, not recruiting
  Leukemia; Multiple Myeloma
  
• Everolimus in a Cyclosporine Microemulsion-Free Regimen Compared to Standard Therapy in de Novo Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00170807 - Recruiting
  Renal Transplantation
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003270 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Cyclosporine in Treating Patients With T-Cell Large Granular Lymphocyte Leukemia
  ClinicalTrials.gov Identifier: NCT00363779 - Recruiting
  Leukemia
  
• SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus
  ClinicalTrials.gov Identifier: NCT00371826 - Recruiting
  Renal Transplantation
  
• A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00332462 - Recruiting
  Liver Transplantation
  
• Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-Transplant
  ClinicalTrials.gov Identifier: NCT00171717 - Active, not recruiting
  Maintenance Liver Transplant Patients With New Onset Diabetes
  
• Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00005988 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00170859 - Recruiting
  Heart Transplantation
  
• A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
  ClinicalTrials.gov Identifier: NCT00402168 - Recruiting
  Renal Transplant
  
• Efficacy and Safety of Enteric-Coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00413920 - Recruiting
  Renal Transplantation
  
• Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00005852 - Active, not recruiting
  Lymphoma; Multiple Myeloma; Leukemia
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
  Leukemia, Myeloid; Leukemia, Myeloid, Chronic
  
• Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-Dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-Term Steroids
  ClinicalTrials.gov Identifier: NCT00239031 - Active, not recruiting
  De Novo Renal Transplantation
  
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Advanced Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00119366 - Recruiting
  adult acute myeloid leukemia; childhood acute myeloid leukemia
  
• Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
  ClinicalTrials.gov Identifier: NCT00349440 - Recruiting
  Dry Eye Syndromes
  
• Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
  ClinicalTrials.gov Identifier: NCT00389870 - Recruiting
  Colorectal Cancer
  
• Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
  ClinicalTrials.gov Identifier: NCT00399061 - Recruiting
  Dry Eye
  
• Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
  ClinicalTrials.gov Identifier: NCT00260208 - Recruiting
  Liver Transplant; Hepatitis C
  
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
  ClinicalTrials.gov Identifier: NCT00502073 - Recruiting
  Dry Eye Syndromes
  
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
  ClinicalTrials.gov Identifier: NCT00548301 - Recruiting
  Dry Eye Syndromes
  
• Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00488436 - Recruiting
  Myelodysplastic Syndrome
  
• Fludarabine and Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer Who are Undergoing a Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00112593 - Recruiting
  adult solid tumor; childhood solid tumor; hematopoietic and lymphoid cancer
  
• A Study to Test the Effect of Cyclosporine on the Immune System of Patients with Early HIV Disease.
  ClinicalTrials.gov Identifier: NCT00000880 - Completed
  HIV Infections
  
• Alemtuzumab, Fludarabine, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00118352 - Recruiting
  childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
  
• Polymorphism of the Cytochrome P450-System and the MDR-System in Renal Transplants Receiving the Immunosuppressive Drugs Tacrolimus, Sirolimus, Everolimus or Cyclosporine A
  ClinicalTrials.gov Identifier: NCT00223054 - Recruiting
  Renal Transplantation
  
• Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00204191 - Recruiting
  Kidney Transplantation
  
• A One-Year, Open Label Study to Investigate the Safety and the Effect of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination with Cyclosporine Microemulsion in De Novo Kidney Transplant Recipients.
  ClinicalTrials.gov Identifier: NCT00154245 - Active, not recruiting
  Kidney Transplantation
  
• A Study to Compare Treatment with Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00005113 - Active, not recruiting
  End-Stage Renal Disease; Kidney Transplantation
  
• Safety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection
  ClinicalTrials.gov Identifier: NCT00084149 - Active, not recruiting
  HIV Infections
  
• Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00004485 - Active, not recruiting
  Sickle Cell Anemia
  
• Efficacy and Safety of a New Multi-Dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms
  ClinicalTrials.gov Identifier: NCT00405457 - Recruiting
  Dry Eye
  
• Alemtuzumab and Cyclosporine in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00217594 - Recruiting
  Myelodysplastic Syndromes
  
• Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00319878 - Recruiting
  Anemia, Aplastic
  
• The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent GVHD Related Dry Eye
  ClinicalTrials.gov Identifier: NCT00553735 - Recruiting
  Graft Versus Host Disease Related Dry Eye
  
• Topical Cyclosporine and Disease Progression
  ClinicalTrials.gov Identifier: NCT00567983 - Recruiting
  Disease Progression; Disease Severity; Staining; Schirmers; OSDI
  
• Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
  ClinicalTrials.gov Identifier: NCT00378677 - Recruiting
  Lung Transplantation; Bronchiolitis Obliterans
  
• Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond to Previous Systemic Treatment
  ClinicalTrials.gov Identifier: NCT00079183 - Active, not recruiting
  Graft Versus Host Disease
  
• Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002961 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission